CN100534454C - Medicine for treating ankylosing spondylitis - Google Patents
Medicine for treating ankylosing spondylitis Download PDFInfo
- Publication number
- CN100534454C CN100534454C CNB2007100145833A CN200710014583A CN100534454C CN 100534454 C CN100534454 C CN 100534454C CN B2007100145833 A CNB2007100145833 A CN B2007100145833A CN 200710014583 A CN200710014583 A CN 200710014583A CN 100534454 C CN100534454 C CN 100534454C
- Authority
- CN
- China
- Prior art keywords
- medicine
- ankylosing spondylitis
- radix
- pain
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament for treating rigid spondylitis, which is prepared from Schizonepeta tenuifolia, cassia twig, Ligusticum wallichii, rhizoma corydalis, mulberry twigs, eucommia bark, acanthopanax root and licorice root through steps of weighing, immersing and grilling twice.
Description
Technical field
The invention belongs to pure technical field of Chinese medicines, specifically a kind of medicine for the treatment of ankylosing spondylitis.
Background technology
Ankylosing spondylitis belongs to motherland's medical science " arthromyodynia ", because Liver and kidney two void, muscles and bones is lost in moistening foster, is subjected to wind, exopathogen such as cold, wet is invaded meridians, cause the meridians obturation, the retardance joint, qi stagnation hemagglutination, or by sprain, medicine irritation, with the passing of time cause spinal joint distortion, enlargement, joint stuffiness, numb pain is ankylosing spondylitis and send out, because distortion disables or loss of life.Adopt all for this type of sick doctor trained in Western medicine that cloth network atmosphere, antiinflammatory are painful etc. to be added the hormone therapy antiinflammatory and relieve the pain, side effect is very big, its cure rate is extremely low, and can only take stopgap measures and to effect a permanent cure, and in human body, easily form residual, influence the healthy of people and can cause other diseases, and the cost height, very big economically burden caused to the people.The Chinese medicine that utilizes that has is boiled into decoction DeGrain for oral administration, can not focus on site of disease to effective efficacy of a drug to reach optimum therapeuticing effect rapidly.What also have utilizes (《 Jin Kui " " Aconiti Decoction ", " Ramulus Cinnamomi paeoniae and Anemarrhenae Decoction ") therapeutic effect is also not obvious.
Purpose of the present invention just is to provide a kind of pure Chinese medicine medicine that can effectively treat ankylosing spondylitis.Medicine of the present invention has promoting the flow of QI in the collateral by warming the meridian, promoting flow of QI and blood, and invigorating the liver and kidney, bone and muscle strengthening, expelling wind and removing dampness, cold expelling relieves the pain, and the purpose of treatment ankylosing spondylitis is fundamentally set about reaching in saturating joint.Medicine of the present invention be applicable to by wind, exopathogen such as cold, wet or sprain, tetanic property lumbar spine inflammation, hyperosteogeny that medicine irritation etc. causes.Medicine of the present invention is formulated by pure Chinese medicine.With the back instant effect, the lighter 5-10 days take effect, and can cure in 30-60 days; Can cure in weight person 60-90 days.10 days is a course of treatment, and the lighter can cure 3 courses of treatment, and weight person 6-9 can cure a course of treatment.Human body is had no side effect, cure the back and be difficult for recurrence.
Summary of the invention
Solution of the present invention is based on the pathogeny of ankylosing spondylitis and the treatment philosophic theory and the treatment by Chinese herbs principle of theory of Chinese medical science " logical person is not bitterly; pain person is obstructed ", with reference to modern pharmacological research, select for use hot temperature medicine to associate with, its hot temperature is enough to cast the midsummer of human body, its effect has changed QI and blood of human body and his like, Rong Yingwei, sharp joint restrains the wind-cold damp pathogen that it invades human body, its arthralgia pain of dispelling has changed the limitation in season that osteoarthritis sick summer controls.Of the present invention is to follow the reason of the medical science rheumatism involving the bone Wen Zhi of motherland and develop, and realizes curing ankylosing spondylitis.
The medicine that the present invention treats ankylosing spondylitis is made by following deal Chinese medicinal raw materials:
Herba Schizonepetae 10-30, Ramulus Cinnamomi 10-24, Rhizoma Chuanxiong 10-24, Rhizoma Corydalis 10-24, Ramulus Mori 15-60, Cortex Eucommiae 10-30, Radix Et Caulis Acanthopanacis Senticosi 10-15, Radix Glycyrrhizae 6-10.
Use the medicine of the present invention's preparation, treatment ankylosing spondylitis effect is obvious, has no side effect, and more the back is difficult for recurrence, effective percentage 100%, cure rate 86%.Case of a physically strong patient running a high fever hyperpyrexia patient forbidding.
Drug action mechanism of the present invention is as follows:
Herba Schizonepetae: acrid in the mouth, warm in nature.Have invigorate blood circulation, promoting the circulation of QI, the merit that relieves the pain.See (Pharmacopoeia of People's Republic of China, Ministry of Health of the People's Republic of China's committee of pharmacopeia is compiled, version in 1977,382 pages).
Ramulus Cinnamomi: acrid in the mouth, sweet, warm in nature.Has temperature three-way meridian, expelling pathogenic factors from muscles, harmonizing yingfen and weifen, the merit of the pain of dispelling.(the same, as to see 468 pages)
Rhizoma Chuanxiong: acrid in the mouth, little hardship, warm in nature.Has promoting flow of QI and blood, the merit of wind-expelling pain-stopping.(the same, as to see 59 pages)
Rhizoma Corydalis: little suffering of distinguishing the flavor of, hardship.Warm in nature.Has blood-activating and qi-promoting, the merit of pain relieving.(the same, as to see 80 pages)
Ramulus Mori: mildly bitter flavor.Property is put down.Merit (the same, as to see 511 pages of the first volumes) with wind-expelling pain-stopping, sharp joint
The Cortex Eucommiae: acrid in the mouth.Warm in nature.Merit with invigorating the liver and kidney, bone and muscle strengthening.(the same, as to see 285 pages)
Radix Et Caulis Acanthopanacis Senticosi: acrid in the mouth, little hardship.Warm in nature.Has replenishing QI to invigorate the spleen, Radix Et Caulis Acanthopanacis Senticosi: the merit of calming the nerves.(the same, as to see 336 pages)
Radix Glycyrrhizae: sweet in the mouth.Property is put down.Have to dispel and swell and ache, the function of coordinating the actions of various ingredients in a prescription.(the same, as to see 130 pages)
Chinese medicine is recognized: be the stasis of gas, and the blockage of main and collateral channels of the Yong Sai meaning of blood, the philosophic theory of " logical person is not bitterly; pain person is obstructed ", dialectical tunnel understands that " ankylosing spondylitis " is that muscles and bones is lost in moistening foster by Liver and kidney two void, be subjected to wind, exopathogen such as cold, wet is invaded meridians, cause the meridians obturation, retardance joint, qi stagnation hemagglutination, or by sprain, medicine irritation, with the passing of time cause spinal joint distortion, enlargement, joint stuffiness, numb pain is ankylosing spondylitis and send out.Walk the back of the body with Herba Schizonepetae among the present invention and go upward to neck along Taiyang channel to invigorate blood circulation, circulation of qi promoting, to relieve the pain; Ramulus Cinnamomi and nutrition blood, the analgesia easing joint movement; With Ramulus Mori walk the upper limb wind-expelling pain-stopping, the upper limb numbness that spondylopathy causes is controlled in sharp joint; The Cortex Eucommiae, Radix Et Caulis Acanthopanacis Senticosi invigorating the liver and kidney, bone and muscle strengthening are to control vertebra degeneration enlargement; The Rhizoma Corydalis blood-activating and qi-promoting, pain relieving is to control spinal joint QI and blood stasis; Rhizoma Chuanxiong draws the up back neck of all medicines, and first circulation of qi promoting is invigorated blood circulation, and with Rong Yingwei, quickens the removing blood stasis with potent drugs detumescence, wind-expelling pain-stopping; The Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription: all medicines are synthetic, have and nourish blood, invigorating the liver and kidney, bone and muscle strengthening, relieve the pain, expelling wind and removing dampness, the merit in promoting the flow of QI in the collateral by warming the meridian, blood circulation promoting and blood stasis dispelling, saturating joint is to reach the purpose of treatment ankylosing spondylitis.
Specific embodiments
The invention will be further described below in conjunction with embodiment:
Embodiment: get Herba Schizonepetae 12, Ramulus Cinnamomi 10, Rhizoma Chuanxiong 12, Rhizoma Corydalis 15, Ramulus Mori 15, the Cortex Eucommiae 20, Radix Et Caulis Acanthopanacis Senticosi 15, Radix Glycyrrhizae 6.Be soaked in water half an hour, fry in shallow oil twice, twice-daily, taking medicine after meal sooner or later.
For showing the curative effect of medicine of the present invention, the 200 routine patients that treat are divided into matched group and experimental group, upright shelves stay to look into is added up contrast.Matched group medication conventional therapy, experimental group Drug therapy of the present invention all is effectively with the sx, transference cure shows that for recovery from illness, statistics the result is as follows:
Table 1: matched group curative effect situation
Table 2, experimental group curative effect situation
For showing that curative effect illustrates:
1: I got ankylosing spondylitis when the Changbai Mountain, and in counties and townships' hospitalize not healing of three more than ten years, the more than ten years do not recur after several tens doses of recoveries from illness of taking medicine after deliberation.
2: Mrs Zhou, 61 years old, Yan Lou Zhen people from Zhouzhuang, Yanggu County before 10 years, suffers from spondylalgia, vertebra and finger-joint enlargement, through counties and townships' hospital diagnosis is ankylosing spondylitis and hyperosteogeny, does not heal in 3 years in counties and townships' hospitalize, and prescription treatment of the present invention is adopted in the back, obey 30 doses of recoveries from illness, follow up a case by regular visits to not recurrence in nearly 5 years.
Claims (2)
1, the medicine of the strong true spondylitis of treatment, it is characterized in that: it is to be made by the medicine of following deal proportioning, Herba Schizonepetae 10-30, Ramulus Cinnamomi 10-24, Rhizoma Chuanxiong 10-24, Rhizoma Corydalis 10-24, Ramulus Mori 15-60, Cortex Eucommiae 10-30, Radix Et Caulis Acanthopanacis Senticosi 10-15, Radix Glycyrrhizae 6-10 are soaked in water half an hour, fry in shallow oil twice.
2, the medicine of the treatment ankylosing spondylitis that requires according to right 1, it is characterized in that: Herba Schizonepetae 12, Ramulus Cinnamomi 10, Rhizoma Chuanxiong 12, Rhizoma Corydalis 15, Ramulus Mori 15, the Cortex Eucommiae 20, Radix Et Caulis Acanthopanacis Senticosi 15, Radix Glycyrrhizae 6 are soaked in water half an hour, fry in shallow oil twice, twice-daily, taking medicine after meal sooner or later.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007100145833A CN100534454C (en) | 2007-04-27 | 2007-04-27 | Medicine for treating ankylosing spondylitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007100145833A CN100534454C (en) | 2007-04-27 | 2007-04-27 | Medicine for treating ankylosing spondylitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101040910A CN101040910A (en) | 2007-09-26 |
| CN100534454C true CN100534454C (en) | 2009-09-02 |
Family
ID=38806839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2007100145833A Expired - Fee Related CN100534454C (en) | 2007-04-27 | 2007-04-27 | Medicine for treating ankylosing spondylitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100534454C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101897928B (en) * | 2010-06-25 | 2012-04-18 | 梁振兴 | Medicinal composition for treating ankylosing spondylitis and preparation method |
-
2007
- 2007-04-27 CN CNB2007100145833A patent/CN100534454C/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| 强直通痹汤治疗强直性脊柱炎30 例. 陈忠跃，周恩庆.陕西中医，第26卷第4期. 2005 |
| 强直通痹汤治疗强直性脊柱炎30 例. 陈忠跃，周恩庆.陕西中医，第26卷第4期. 2005 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101040910A (en) | 2007-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101411802B (en) | Black plaster for treating hyperosteogeny and preparation method thereof | |
| CN103386008B (en) | Chinese medicine composition for treating endocrine dyscrasia | |
| CN102698002B (en) | Medicinal liquor for treating rheumatism, rheumatoid and pains of neck, shoulders, waist and legs | |
| CN103417742A (en) | Traditional Chinese medicine for curing cervical spondylosis and lumbar intervertebral disc hernia | |
| CN100998656A (en) | Medicated wine for tonifying bone and removing obstruction in channels | |
| CN104225508A (en) | Traditional Chinese medicine composition for cervical spondylosis treatment and preparation method thereof | |
| CN104306540B (en) | A kind of treat Chinese medicine preparation of numb limbs and tense tendons and preparation method thereof after brain tumor surgery | |
| CN101214318B (en) | Medicinal liquor for treating rheumatism, rheumatoid and various hyperosteogeny | |
| CN104258366A (en) | Traditional Chinese medicine preparation for lumbago and preparation method thereof | |
| CN102475868A (en) | Anti-rheumatism medicinal liquor | |
| CN103721082B (en) | A kind of Chinese medicine composition of cure scapulohumeral periarthritis | |
| CN104784614A (en) | Traditional Chinese medicine composition for treating kidney deficiency | |
| CN100534454C (en) | Medicine for treating ankylosing spondylitis | |
| CN103830672A (en) | Traditional Chinese medicine for treating scapulohumeral periarthritis | |
| CN103845620A (en) | Traditional Chinese medicine for treating raynaud disease | |
| CN103893309A (en) | Medicament for treating rheumatoid arthritis | |
| CN102441131A (en) | Chinese medicinal composition for treating traumatic injury | |
| CN101721479A (en) | Chinese herbal medicine preparation for treating rheumatalgia | |
| CN101468095A (en) | Pharmaceutical composition for treating protrusion of lumbar vertebral disc | |
| CN104027764A (en) | Medicine for treating rheumatoid bone diseases | |
| CN103463397A (en) | Traditional Chinese medicine composition for treating deficiency of kidney-yin | |
| CN1342478A (en) | Medical wine for treating rheumatism | |
| CN106389943A (en) | Traditional Chinese medicinal composition for treating back myofascitis | |
| CN102366591B (en) | Chinese herbal medicinal wine for treating rheumatoid and rheumatoid arthritis and its preparation method | |
| CN100435833C (en) | Medicine for treating Bi syndrome and method for preparing same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090902 Termination date: 20110427 |